We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Braskem (BAK) in Focus: Stock Moves 5.2% Higher
Braskem S.A. (BAK - Free Report) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 17.5% in the past one-month time frame.
The company has seen one positive estimate revision in the past one month, while its Zacks Consensus Estimate has also moved higher over the same time frame, suggesting that more solid trading could be ahead for Braskem. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Braskem currently sports a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Braskem S.A. Price
Braskem S.A. Price | Braskem S.A. Quote
Another stock worth considering in the Oil and Gas - Integrated - International industry is OMV Aktiengesellschaft (OMVJF - Free Report) , which sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Is BAK going up? Or down? Predict to see what others think: Up or Down
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>